Optimal Transport System for Acute Ischemic Stroke Patients: A Cost-Effectiveness Analysis

Stud Health Technol Inform. 2024 Jan 25:310:1558-1559. doi: 10.3233/SHTI231292.

Abstract

This study conducted cost utility analysis comparing 4 systems of transporting acute ischemic stroke patients in Hokkaido, Japan. Hypothetical patients were generated on a geographic information system, and their outcomes were estimated according to their transport time to hospitals administering tissue plasminogen activator and/or endovascular thrombectomy. The transport systems where a neurointerventionist traveled for earlier endovascular thrombectomy were most cost-effective in some rural areas, while direct transportation to comprehensive stroke centers was more cost-effective in other areas.

Keywords: Acute ischemic stroke; Cost-effectiveness; Transport system.

MeSH terms

  • Cost-Benefit Analysis
  • Cost-Effectiveness Analysis
  • Humans
  • Ischemic Stroke*
  • Stroke* / therapy
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Tissue Plasminogen Activator